Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimum Effective Volume of Bupivacaine 0.5% for Ultrasound-guided Retroclavicular Approach to Infraclavicular Brachial Plexus Block

NCT03472911 is registered in ClinicalTrials.gov with Antalya Training and Research Hospital as lead sponsor.

NCT NCT03472911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03472911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimum Effective Volume of Bupivacaine 0.5% for Ultrasound-guided Retroclavicular Approach to Infraclavicular Brachial Plexus Block
Lead sponsor
Antalya Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
January 8, 2018
Completion date
March 15, 2018
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bupivacaine